← Leaderboards
Sandrasegaram Gnanakaran
University Of Oklahoma
$2,954,902
Attributed
$10,384,980
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,384,980 · 3
By mechanism
R01$10,384,980 · 3
Top collaborators
- Cynthia Ann Derdeyn5 shared
- Paolo Ruggerone5 shared
- Valentin V Rybenkov5 shared
- John K. Walker5 shared
- Helen I. Zgurskaya5 shared
- Kelly Keisen Lee3 shared
Most similar at University Of Oklahoma
Same institution · by research overlap
- Paolo Ruggerone$1,146,424
- Daniel Becker$527,384
Others in their field
Other Emerging Leaders on “Membrane”
- Ted Ross · University Of Georgia$71,962,304
- Gary Fanger · Rise Therapeutics, Llc$21,703,466
- Thomas Denny · Duke University$19,381,749
- Leonard Freedman · Leidos Biomedical Research, Inc.$15,756,756
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$10,599,402
- Mary E Hamby · Cognition Therapeutics, Inc.$9,832,688
Research focus
MembraneMolecular DynamicsCellsMolecularBiochemistryResistanceInfectionMachine LearningStructureSynergismMulti-Scale ModelingTransmission ProcessSimulationIn VitroBindingDesignInnovationInsightHiv-1EpitopesHiv Envelope ProteinBiochemicalIn SilicoVariant
Grant awards (10)
Interplay of the HIV-1 Env cytoplasmic tail, Gag-MA, and membrane: resolving molecular detail and blocking assembly$1,505,957
R01 · FY2025 · AI
Exploiting glycan holes and sequence diversity of naturally occurring HIV envelope towards the design of vaccine immunogen panels for induction of neutralization breadth$802,686
R01 · FY2025 · AI
Interplay of the HIV-1 Env cytoplasmic tail, Gag-MA, and membrane: resolving molecular detail and blocking assembly$774,186
R01 · FY2024 · AI
Exploiting glycan holes and sequence diversity of naturally occurring HIV envelope towards the design of vaccine immunogen panels for induction of neutralization breadth$742,463
R01 · FY2024 · AI
Interplay of the HIV-1 Env cytoplasmic tail, Gag-MA, and membrane: resolving molecular detail and blocking assembly$827,566
R01 · FY2023 · AI
Optimization of efflux avoidance and inhibition for antibiotic development$1,099,291
R01 · FY2022 · AI
Optimization of efflux avoidance and inhibition for antibiotic development$1,106,111
R01 · FY2021 · AI
Optimization of efflux avoidance and inhibition for antibiotic development$1,048,793
R01 · FY2020 · AI
Optimization of efflux avoidance and inhibition for antibiotic development$1,056,326
R01 · FY2019 · AI
Optimization of efflux avoidance and inhibition for antibiotic development$1,421,601
R01 · FY2018 · AI